| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 73 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14 | -73 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14 | -73 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biosercod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 573 | 567 | 558 | 547 | 537 | 527 | 515 | 516 | 515 | 512 |
| Current Assets | 77 | 193 | 159 | 156 | 153 | 216 | 211 | 202 | 187 | 112 |
| Inventories | 38 | 64 | 80 | 78 | 77 | 75 | 74 | 74 | 74 | 0 |
| Receivables | 0 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Cash | 38 | 84 | 36 | 35 | 35 | 99 | 97 | 87 | 73 | 72 |
| Shareholders Funds | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 67 | -7 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 1.657 | 1.748 | 1.718 | 1.687 | 1.654 | 1.726 | 1.688 | 1.693 | 1.688 | 1.679 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Biosercod S.r.l.